Rosell-Mases E, Santiago A, Corral-Pujol M, Yanez F, Varela E, Egia-Mendikute L
Nat Commun. 2023; 14(1):7770.
PMID: 38012160
PMC: 10682479.
DOI: 10.1038/s41467-023-43652-x.
Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso L, Scaldaferri F
Intern Emerg Med. 2023; 19(2):275-293.
PMID: 37505311
PMC: 10954893.
DOI: 10.1007/s11739-023-03374-w.
Pantoja-Feliciano I, Karl J, Perisin M, Doherty L, McClung H, Armstrong N
BMC Microbiol. 2023; 23(1):32.
PMID: 36707764
PMC: 9883884.
DOI: 10.1186/s12866-023-02776-2.
Mortera S, Marzano V, Vernocchi P, Matteoli M, Guarrasi V, Gardini S
Int J Mol Sci. 2022; 23(24).
PMID: 36555624
PMC: 9787575.
DOI: 10.3390/ijms232415982.
Zeng L, Deng Y, Yang K, Chen J, He Q, Chen H
Front Immunol. 2022; 13:944387.
PMID: 36248877
PMC: 9562921.
DOI: 10.3389/fimmu.2022.944387.
Impact of Geographical Location on the Gut Microbiota Profile in Egyptian Children with Type 1 Diabetes Mellitus: A Pilot Study.
Elsherbiny N, Ramadan M, Abu Faddan N, Hassan E, Ali M, Abd El-Rehim A
Int J Gen Med. 2022; 15:6173-6187.
PMID: 35864993
PMC: 9296103.
DOI: 10.2147/IJGM.S361169.
Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions.
Spisni E, Turroni S, Alvisi P, Spigarelli R, Azzinnari D, Ayala D
Front Pharmacol. 2022; 13:841782.
PMID: 35370685
PMC: 8971809.
DOI: 10.3389/fphar.2022.841782.
Causal Relationship Between Gut Microbiota and Autoimmune Diseases: A Two-Sample Mendelian Randomization Study.
Xu Q, Ni J, Han B, Yan S, Wei X, Feng G
Front Immunol. 2022; 12:746998.
PMID: 35140703
PMC: 8819003.
DOI: 10.3389/fimmu.2021.746998.
Metaproteomics Approach and Pathway Modulation in Obesity and Diabetes: A Narrative Review.
Calabrese F, Porrelli A, Vacca M, Comte B, Nimptsch K, Pinart M
Nutrients. 2022; 14(1).
PMID: 35010920
PMC: 8746330.
DOI: 10.3390/nu14010047.
The Role of the Gut Microbiota in the Pathogenesis of Diabetes.
Bielka W, Przezak A, Pawlik A
Int J Mol Sci. 2022; 23(1).
PMID: 35008906
PMC: 8745411.
DOI: 10.3390/ijms23010480.
Possible Benefits of for Obesity-Associated Gut Disorders.
Maioli T, Borras-Nogues E, Torres L, Barbosa S, Martins V, Langella P
Front Pharmacol. 2021; 12:740636.
PMID: 34925006
PMC: 8677946.
DOI: 10.3389/fphar.2021.740636.
The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease.
Zaky A, Glastras S, Wong M, Pollock C, Saad S
Int J Mol Sci. 2021; 22(17).
PMID: 34502562
PMC: 8431784.
DOI: 10.3390/ijms22179641.
Insights from Species in Children with Type 1 Diabetes.
Matos J, Matos I, Calha M, Santos P, Duarte I, Cardoso Y
Microorganisms. 2021; 9(7).
PMID: 34361871
PMC: 8306409.
DOI: 10.3390/microorganisms9071436.
Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children.
Torun A, Hupalowska A, Trzonkowski P, Kierkus J, Pyrzynska B
Front Immunol. 2021; 12:642166.
PMID: 34163468
PMC: 8215716.
DOI: 10.3389/fimmu.2021.642166.
Impact of type 1 diabetes on the composition and functional potential of gut microbiome in children and adolescents: possible mechanisms, current knowledge, and challenges.
Mokhtari P, Metos J, Anandh Babu P
Gut Microbes. 2021; 13(1):1-18.
PMID: 34101547
PMC: 8205092.
DOI: 10.1080/19490976.2021.1926841.
Microbial Ecosystem in Diabetes Mellitus: Consideration of the Gastrointestinal System.
Yehualashet A, Yikna B
Diabetes Metab Syndr Obes. 2021; 14:1841-1854.
PMID: 33953584
PMC: 8089103.
DOI: 10.2147/DMSO.S304497.
Dysbiosis in the Development of Type I Diabetes and Associated Complications: From Mechanisms to Targeted Gut Microbes Manipulation Therapies.
Gradisteanu Pircalabioru G, Corcionivoschi N, Gundogdu O, Chifiriuc M, Marutescu L, Ispas B
Int J Mol Sci. 2021; 22(5).
PMID: 33803255
PMC: 7967220.
DOI: 10.3390/ijms22052763.
The Multiomics Analyses of Fecal Matrix and Its Significance to Coeliac Disease Gut Profiling.
Gangadoo S, Rajapaksha Pathirannahalage P, Cheeseman S, Dang Y, Elbourne A, Cozzolino D
Int J Mol Sci. 2021; 22(4).
PMID: 33671197
PMC: 7922330.
DOI: 10.3390/ijms22041965.
An association between chronic widespread pain and the gut microbiome.
Freidin M, Stalteri M, Wells P, Lachance G, Baleanu A, Bowyer R
Rheumatology (Oxford). 2020; 60(8):3727-3737.
PMID: 33331911
PMC: 8328510.
DOI: 10.1093/rheumatology/keaa847.
NLR and Intestinal Dysbiosis-Associated Inflammatory Illness: Drivers or Dampers?.
Elias-Oliveira J, Leite J, Pereira I, Guimaraes J, Manso G, Silva J
Front Immunol. 2020; 11:1810.
PMID: 32903730
PMC: 7438795.
DOI: 10.3389/fimmu.2020.01810.